ios-H5
N/A
Report date: 2023/02/19 20:08:09
NME
Base Information
Drug Nameios-H5
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunOs Therapeutics AG
China Registration ClassN/A
Develop Information
Active CompaniesImmunOs Therapeutics AG
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A